Patent ID: 11872276
Assignee: INSTITUT PASTEUR
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C  Y | IPC A  C

Claim 5:
6. The pharmaceutical composition of claim 1, wherein the chimeric polyepitope further comprises at least one T-cell epitope of a ZIKV protein selected from the group consisting of:
(i) a T-cell epitope of the C protein of a ZIKV comprising or consisting of an amino acid sequence selected from the group consisting of SEQ ID NOs: 1, 2, 4-6 and 75,
(ii) a T-cell epitope of the E protein of a ZIKV comprising or consisting of an amino acid sequence selected from the group consisting of SEQ ID NOs: 7, 76 and 77,
(iii) a T-cell epitope of the NS2B protein of a ZIKV comprising or consisting of the amino acid sequence of SEQ ID NO: 25,
(iv) a T-cell epitope of the NS4A protein of a ZIKV comprising or consisting of the amino acid sequence of SEQ ID NO: 36, and
(v) a T-cell epitope of the NS4B protein of a ZIKV comprising or consisting of the amino acid sequence selected from the group consisting of SEQ ID NOs: 40-43.